Neurotrophic keratopathy (corneal nerve damage reducing healing capacity)
In most studies, a study population with pre-existing cardiovascular disease is chosen in order to aim at a higher event rate in a shorter study duration (5461)
Susana Monereo destaca la trascendencia de estos avances: "Los frmacos actuales son un hito, pues modulan a nivel cerebral los mecanismos de regulacin del hambre y la saciedad, ofreciendo as un nuevo paradigma en el manejo de la obesidad." Los tratamientos farmacolgicos modernos para la obesidad incluyen agentes que actan directamente sobre los centros de hambre y saciedad en el cerebro y alteran las vas metablicas para reducir el almacenamiento de grasa y aumentar el gasto energtico
[15] [16] Tirzepatide (Mounjaro) , a dual GIP/GLP-1 receptor agonist, has also received NICE approval for managing overweight and obesity in adults meeting defined criteria
In this guide, I will break down the science behind these two powerhouses, explain how they differ, and show you how to choose the right one for your needsor even how to use them together safely under professional guidance
Youll receive your medication vial, syringes, alcohol wipes, and easy-to-follow injection and storage instructions, all shipped in a temperature-controlled package
